205 related articles for article (PubMed ID: 12765471)
1. Immunosuppressive drug use in pregnancy.
Petri M
Autoimmunity; 2003 Feb; 36(1):51-6. PubMed ID: 12765471
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacotherapy of SLE].
Nakazawa T; Kumagai S; Kogata Y
Nihon Rinsho; 2005 May; 63 Suppl 5():253-9. PubMed ID: 15954358
[No Abstract] [Full Text] [Related]
3. Immunosuppressive medication use and risk of herpes zoster (HZ) in patients with systemic lupus erythematosus (SLE): A nationwide case-control study.
Hu SC; Yen FL; Wang TN; Lin YC; Lin CL; Chen GS
J Am Acad Dermatol; 2016 Jul; 75(1):49-58. PubMed ID: 26946984
[TBL] [Abstract][Full Text] [Related]
4. Prospective randomized pilot study of steroid withdrawal with mycophenolate mofetil in long-term cyclosporine-treated patients: 4-year follow-up.
Budde K; Geissler S; Hallebach G; Waiser J; Fritsche L; Böhler T; Neumayer HH
Transplant Proc; 2002 Aug; 34(5):1703-5. PubMed ID: 12176544
[No Abstract] [Full Text] [Related]
5. Update on immunosuppressive therapy.
Singer NG; McCune WJ
Curr Opin Rheumatol; 1998 May; 10(3):169-73. PubMed ID: 9608317
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppressive drug use during pregnancy.
Ramsey-Goldman R; Schilling E
Rheum Dis Clin North Am; 1997 Feb; 23(1):149-67. PubMed ID: 9031380
[TBL] [Abstract][Full Text] [Related]
7. [Other immunosuppressants: azathioprine (Imurel), mycophenolate mofetil (Cellcept), cyclophosphamide (Endoxan)].
Gaudy-Marqueste C
Ann Dermatol Venereol; 2007 Dec; 134(12):949-56. PubMed ID: 18166916
[No Abstract] [Full Text] [Related]
8. Update οn the diagnosis and management of systemic lupus erythematosus.
Fanouriakis A; Tziolos N; Bertsias G; Boumpas DT
Ann Rheum Dis; 2021 Jan; 80(1):14-25. PubMed ID: 33051219
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppressive and cytotoxic therapy: pharmacology, toxicities, and monitoring.
Wang T; Weigt SS; Belperio JA; Lynch JP
Semin Respir Crit Care Med; 2011 Jun; 32(3):346-70. PubMed ID: 21674420
[TBL] [Abstract][Full Text] [Related]
10. Drug therapy in the heart transplant recipient: part II: immunosuppressive drugs.
Lindenfeld J; Miller GG; Shakar SF; Zolty R; Lowes BD; Wolfel EE; Mestroni L; Page RL; Kobashigawa J
Circulation; 2004 Dec; 110(25):3858-65. PubMed ID: 15611389
[No Abstract] [Full Text] [Related]
11. Immunosuppressive drug therapy.
McCune WJ; Vallance DK; Lynch JP
Curr Opin Rheumatol; 1994 May; 6(3):262-72. PubMed ID: 8060760
[TBL] [Abstract][Full Text] [Related]
12. Effects of immunosuppressive drugs during pregnancy.
Bermas BL; Hill JA
Arthritis Rheum; 1995 Dec; 38(12):1722-32. PubMed ID: 8849343
[No Abstract] [Full Text] [Related]
13. Omission of azathioprine and mycophenolate mofetil in immunosuppressive regimen in kidney transplantation.
Taheri M; Pourmand G; Mehrsai AR; Mansoori D
Transplant Proc; 2003 Nov; 35(7):2752-3. PubMed ID: 14612105
[No Abstract] [Full Text] [Related]
14. Longitudinal Treatment Patterns and Associated Outcomes in Patients With Newly Diagnosed Systemic Lupus Erythematosus.
Kan H; Nagar S; Patel J; Wallace DJ; Molta C; Chang DJ
Clin Ther; 2016 Mar; 38(3):610-24. PubMed ID: 26907503
[TBL] [Abstract][Full Text] [Related]
15. Immunosuppressive and cytotoxic drugs in the treatment of rheumatic skin disorders.
Callen JP
Semin Cutan Med Surg; 2001 Mar; 20(1):58-68. PubMed ID: 11308138
[TBL] [Abstract][Full Text] [Related]
16. Relation of mycophenolic acid trough levels and adverse events in kidney allograft recipients.
Smak Gregoor PJ; Hesse CJ; van Gelder T; van der Mast BJ; IJzermans JN; van Besouw NM; Weimar W
Transplant Proc; 1998 Jun; 30(4):1192-3. PubMed ID: 9636482
[No Abstract] [Full Text] [Related]
17. Factors associated with fetal losses in severe systemic lupus erythematosus.
Martínez-Rueda JO; Arce-Salinas CA; Kraus A; Alcocer-Varela J; Alarcón-Segovia D
Lupus; 1996 Apr; 5(2):113-9. PubMed ID: 8743123
[TBL] [Abstract][Full Text] [Related]
18. Improved outcome of steroid withdrawal in mycophenolate mofetil-treated primary cadaveric renal transplant recipients.
Kupin W; Venkat KK; Goggins M; Douzdjian V; Escobar F; Mozes M; Abouljoud M
Transplant Proc; 1999; 31(1-2):1131-2. PubMed ID: 10083505
[No Abstract] [Full Text] [Related]
19. Cyclosporin A and therapeutic plasma exchange in the treatment of severe systemic lupus erythematosus.
Bambauer R; Schwarze U; Schiel R
Artif Organs; 2000 Nov; 24(11):852-6. PubMed ID: 11119071
[TBL] [Abstract][Full Text] [Related]
20. Comparative Rates of Serious Infections Among Patients With Systemic Lupus Erythematosus Receiving Immunosuppressive Medications.
Feldman CH; Marty FM; Winkelmayer WC; Guan H; Franklin JM; Solomon DH; Costenbader KH; Kim SC
Arthritis Rheumatol; 2017 Feb; 69(2):387-397. PubMed ID: 27589220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
